These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38158474)

  • 1. Data-driven development of an oral lipid-based nanoparticle formulation of a hydrophobic drug.
    Bao Z; Yung F; Hickman RJ; Aspuru-Guzik A; Bannigan P; Allen C
    Drug Deliv Transl Res; 2024 Jul; 14(7):1872-1887. PubMed ID: 38158474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized Nanoparticles for Enhanced Oral Bioavailability of a Poorly Soluble Drug: Solid Lipid Nanoparticles Versus Nanostructured Lipid Carriers.
    Darwish MKM; El-Enin ASMA; Mohammed KHA
    Pharm Nanotechnol; 2022; 10(1):69-87. PubMed ID: 35142275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets.
    Koch N; Jennotte O; Bourcy Q; Lechanteur A; Deville M; Charlier C; Chiap P; Cardot JM; Evrard B
    Int J Pharm; 2024 May; 657():124173. PubMed ID: 38685441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
    Cherniakov I; Izgelov D; Domb AJ; Hoffman A
    Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus.
    Yu Q; Hu X; Ma Y; Xie Y; Lu Y; Qi J; Xiang L; Li F; Wu W
    Drug Deliv; 2016 May; 23(4):1469-75. PubMed ID: 27187522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
    Das S; Chaudhury A
    AAPS PharmSciTech; 2011 Mar; 12(1):62-76. PubMed ID: 21174180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly water-soluble mast cell stabiliser-encapsulated solid lipid nanoparticles with enhanced oral bioavailability.
    Patel RR; Chaurasia S; Khan G; Chaubey P; Kumar N; Mishra B
    J Microencapsul; 2016 May; 33(3):209-20. PubMed ID: 26885889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
    Neves AR; Lúcio M; Martins S; Lima JL; Reis S
    Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
    Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
    Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
    Ramalingam P; Ko YT
    Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method.
    Nabi-Meibodi M; Vatanara A; Najafabadi AR; Rouini MR; Ramezani V; Gilani K; Etemadzadeh SM; Azadmanesh K
    Colloids Surf B Biointerfaces; 2013 Dec; 112():408-14. PubMed ID: 24036624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
    Chen CC; Tsai TH; Huang ZR; Fang JY
    Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles.
    Zhang Y; Li Z; Zhang K; Yang G; Wang Z; Zhao J; Hu R; Feng N
    Int J Pharm; 2016 Sep; 511(1):57-64. PubMed ID: 27374194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.